Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Baselga
Larry Norton

Cancer cell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Cell|September 3, 2002
A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerizationJose Baselga
Cancer Cell|June 15, 2004
Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?Carlos L Arteaga, Jose Baselga
Cancer Cell|September 13, 2011
Tumor entrained neutrophils inhibit seeding in the premetastatic lungZvi Granot, Erik Henke, Elizabeth A Comen, et al.
Cancer Cell|January 11, 2011
AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activitySarat Chandarlapaty, Ayana Sawai, Maurizio Scaltriti, et al.
Cancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.
Cancer Cell|February 13, 2007
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B geneAlejandra Bruna, Rachel S Darken, Federico Rojo, et al.
Cancer Cell|April 7, 2009
TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastomaSilvia Peñuelas, Judit Anido, Rosa M Prieto-Sánchez, et al.
Cancer Cell|December 12, 2018
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo PathwayZhiqiang Li, Pedram Razavi, Qing Li, et al.
Cancer Cell|November 1, 2019
Paradigms for Precision Medicine in Epichaperome Cancer TherapyNagavarakishore Pillarsetty, Komal Jhaveri, Tony Taldone, et al.
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Cell|September 3, 2002
A new anti-ErbB2 strategy in the treatment of cancer: prevention of ligand-dependent ErbB2 receptor heterodimerizationJose Baselga
Cancer Cell|June 15, 2004
Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them?Carlos L Arteaga, Jose Baselga
Cancer Cell|September 13, 2011
Tumor entrained neutrophils inhibit seeding in the premetastatic lungZvi Granot, Erik Henke, Elizabeth A Comen, et al.
Cancer Cell|January 11, 2011
AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activitySarat Chandarlapaty, Ayana Sawai, Maurizio Scaltriti, et al.
Cancer Cell|July 4, 2009
Latent bone metastasis in breast cancer tied to Src-dependent survival signalsXiang H-F Zhang, Qiongqing Wang, William Gerald, et al.
Cancer Cell|February 13, 2007
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B geneAlejandra Bruna, Rachel S Darken, Federico Rojo, et al.
Cancer Cell|April 7, 2009
TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastomaSilvia Peñuelas, Judit Anido, Rosa M Prieto-Sánchez, et al.
Cancer Cell|December 12, 2018
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo PathwayZhiqiang Li, Pedram Razavi, Qing Li, et al.
Cancer Cell|November 1, 2019
Paradigms for Precision Medicine in Epichaperome Cancer TherapyNagavarakishore Pillarsetty, Komal Jhaveri, Tony Taldone, et al.
Cancer Cell|September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersPedram Razavi, Matthew T Chang, Guotai Xu, et al.
Pageof 1